Premium
Reinventing Bioinnovation
Author(s) -
Kaitin K I,
Honig P K
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2013.129
Subject(s) - clinical pharmacology , engineering ethics , government (linguistics) , drug development , forcing (mathematics) , pharmacology , medicine , management science , drug , engineering , philosophy , linguistics , climatology , geology
The landscape for bioinnovation is undergoing a seismic shift as drug developers, regulators, academic institutions, and government research organizations adapt to the formidable challenge of bringing new medicines to market. The inability to translate current advances in the scientific understanding of disease into new therapeutics is forcing all sectors to replace traditional drug development paradigms with newer and more efficient models. This issue of Clinical Pharmacology & Therapeutics explores these changes to the bioinnovation ecosystem. Clinical Pharmacology & Therapeutics (2013); 94 3, 279–283. doi: 10.1038/clpt.2013.129